Cardiosense

Cardiosense is a Chicago-based, private digital health company founded in 2017, focusing on the early detection and management of cardiovascular disease. Its integrated platform centers on the CardioTag™, a medical-grade wearable sensor that captures seismocardiogram (SCG), photoplethysmogram (PPG), and electrocardiogram (ECG) signals. Proprietary deep learning algorithms analyze these signals to generate predictive digital biomarkers for conditions like heart failure. The company aims to shift cardiac care from reactive to proactive by identifying measurable changes in cardiovascular function before symptoms appear.

Multimodal wearable sensor (SCG, PPG, ECG) combined with deep learning AI algorithms to generate predictive digital biomarkers for cardiac dysfunction.

Cardiosense competes in a crowded field including large medtech companies (e.g., Medtronic, Abbott) with implantable monitors and ECG patches, and numerous startups focused on wearable ECG and PPG-based analytics. Its differentiation lies in its multimodal approach, particularly the incorporation of seismocardiography (SCG) to assess cardiac mechanics, which may provide earlier and more specific signals of dysfunction than rhythm-based monitoring alone.